लोड हो रहा है...

A novel pancreatic β-cell targeting bispecific-antibody (BsAb) can prevent the development of Type 1 diabetes in NOD mice

To prepare a novel Bispecific Antibody (BsAb) as a potential targeted therapy for T1D, we produced a “functionally inert” monoclonal antibody (mAb) against Glucose transporter-2 (GLUT-2) expressed on β-cells to serve as an anchoring antibody. The therapeutic arm is an agonistic mAb against Cytotoxic...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Bhattacharya, Palash, Fan, Jilao, Haddad, Christine, Essani, Abdul, Gopisetty, Anupama, Elshabrawy, Hatem A, Vasu, Chenthamarakshan, Prabhakar, Bellur S.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2014
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4077286/
https://ncbi.nlm.nih.gov/pubmed/24792135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2014.04.014
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!